Menu
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Analog Devices (ADI) Is Up 4.23% in One Week: What You Should Know
Analog Devices (ADI) Is Up 4.23% in One Week: What You Should Know

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even

908 Devices (MASS) Upgraded to Buy: Here's Why
908 Devices (MASS) Upgraded to Buy: Here's Why

908 Devices Inc. (MASS) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is

Are You Looking for a Top Momentum Pick? Why Heartland Express (HTLD) is a Great Choice
Are You Looking for a Top Momentum Pick? Why Heartland Express (HTLD) is a Great Choice

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell

Southern Missouri Bancorp (SMBC) Upgraded to Buy: Here's What You Should Know
Southern Missouri Bancorp (SMBC) Upgraded to Buy: Here's What You Should Know

Investors might want to bet on Southern Missouri Bancorp (SMBC), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings

KalVista Pharmaceuticals (KALV) Upgraded to Buy: What Does It Mean for the Stock?Photo, wide shot, wide-angle lens,  Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/80e18bfd-1ff8-4487-af62-1cdb7de1ceb6.png
KalVista Pharmaceuticals (KALV) Upgraded to Buy: What Does It Mean for the Stock?

KalVista Pharmaceuticals, Inc. (KALV) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces

What Makes Valmont Industries (VMI) a Strong Momentum Stock: Buy Now?
What Makes Valmont Industries (VMI) a Strong Momentum Stock: Buy Now?

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell

Citizens Financial Group (CFG) Upgraded to Buy: Here's What You Should Know
Citizens Financial Group (CFG) Upgraded to Buy: Here's What You Should Know

Investors might want to bet on Citizens Financial Group (CFG), as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings

Rocket Lab Is Down 24% From Its 52-Week High—Pullback or Problem?Photo, wide shot, wide-angle lens, soft focus,  Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-pKgbwxVSbyTCu0UzPNe8NL8D.png?st=2023-05-04T16%3A02%3A58Z&se=2023-05-04T18%3A02%3A58Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-04T12%3A13%3A51Z&ske=2023-05-05T12%3A13%3A51Z&sks=b&skv=2021-08-06&sig=%2BhYssNp3W0HiZMxCV64XVELyP8stYUjFhgUVfPrTLyg%3D
Rocket Lab Is Down 24% From Its 52-Week High—Pullback or Problem?

Key Points

Space ETFs Skyrocket in May: Can the Rally Last?
Space ETFs Skyrocket in May: Can the Rally Last?

Space-related stocks witnessed a massive rally in May as excitement builds around the highly anticipated IPO of SpaceX, which could become the largest public offering ever. According to The Wall

ASTS Plagued by Competitive Pressure, Macro Risks: Time to Rethink?
ASTS Plagued by Competitive Pressure, Macro Risks: Time to Rethink?

AST SpaceMobile, Inc. ASTS continues to navigate a challenging operating environment, plagued by margin and macroeconomic headwinds. The company operates in a capital-intensive phase, requiring

RZLT Stock on the Move: What Sparks the 38% Jump in the Past Week?
RZLT Stock on the Move: What Sparks the 38% Jump in the Past Week?

Shares of Rezolute RZLT rose 38% over the past week, driven by positive interim results from the late-stage upLIFT study evaluating its lead candidate, ersodetug, in patients with tumor

UBER Stock Price Decreases 12% YTD: Exit Now or Stay Put?
UBER Stock Price Decreases 12% YTD: Exit Now or Stay Put?

Shares of Uber Technologies UBER have declined 12.3% so far this year, underperforming the Zacks Internet-Services industry and the S&P 500 Index, of which it is a key member. In comparison, shares

KTOS Stock Declines 6% in a Month: Opportunity or Warning Sign?Photo, wide shot, wide-angle lens,  Logistics company, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/a16a79c7-f73c-405d-ba63-e8d69b66ce4e.png
KTOS Stock Declines 6% in a Month: Opportunity or Warning Sign?

Kratos Defense & Security Solutions, Inc.’s KTOS shares have lost 6% in the past month against the Zacks Aerospace-Defense Equipment industry’s growth of 12.7%. The company remains a key provider of

Subsea7 Secures String Music Development Contract in the U.S. GulfPhoto, wide shot, wide-angle lens,  Gold mine, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/94faf2bd-99c1-4ea6-b55d-fdcab23c3865.png
Subsea7 Secures String Music Development Contract in the U.S. Gulf

Subsea7 S.A. SUBCY announced that it has secured a contract to work for the String Music development in the U.S. Gulf. The contract has been awarded by Murphy Exploration & Production Company, an

Celestica Rides on Organic Growth: Reason to Buy the Stock Now?Photo, wide shot, wide-angle lens,  Consumer electronics manufacturer, Midday, harsh overhead sunlight, directional sunlightt, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/0defe5ca-333a-451e-9549-4f262e278fc7.png
Celestica Rides on Organic Growth: Reason to Buy the Stock Now?

Celestica Inc. CLS continues to benefit from robust organic growth, driven by strong demand for its cloud and networking solutions. The company is gaining from increased investments by hyperscale

Reasons to Add Tandem Diabetes Stock to Your Portfolio Right Now
Reasons to Add Tandem Diabetes Stock to Your Portfolio Right Now

Tandem Diabetes Care, Inc.’s TNDM appears well positioned for growth, supported by its successful strategic business model transition. The company's expanding international presence is expected to

Here's How Financial Strength Remains a Key Advantage for GMEDPhoto, wide shot, wide-angle lens,  Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png
Here's How Financial Strength Remains a Key Advantage for GMED

Globus Medical GMED maintains a strong balance sheet and liquidity position, providing significant financial flexibility to execute its growth strategy. As of the end of the first quarter of 2026

Can Boeing's Commercial Aircraft Delivery Momentum Lift Performance?
Can Boeing's Commercial Aircraft Delivery Momentum Lift Performance?

The Boeing Company BA appears to be making steady progress in its turnaround efforts, supported by improving commercial aircraft production and delivery trends.During first-quarter 2026, Boeing

Buy These Renewable Energy & Battery Stocks Amid Global Energy Crisis
Buy These Renewable Energy & Battery Stocks Amid Global Energy Crisis

An updated edition of the April 16, 2026, article. 

As industries worldwide increasingly embrace the global energy transition in pursuit of the 2050 net-zero goal, investment in clean energy has

Arcus, Bristol Myers Team Up to Advance Kidney Cancer StudyPhoto, wide shot, wide-angle lens,  Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png
Arcus, Bristol Myers Team Up to Advance Kidney Cancer Study

Arcus Biosciences RCUS announced a clinical trial collaboration and supply agreement with Bristol Myers Squibb BMY to evaluate casdatifan in combination with PD L1/VEGF A bispecific immunomodulator.

AXT's Order Backlog Surge & Capacity Push Fuel Growth ExpectationsPhoto, wide shot, wide-angle lens,  Telecom equipment supplier, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.theapi.app/temp/3967c11c-b755-4d39-87d0-acc853384c80.png
AXT's Order Backlog Surge & Capacity Push Fuel Growth Expectations

AXT AXTI is emerging as one of the most compelling beneficiaries of the artificial intelligence infrastructure buildout, with demand for its indium phosphide substrates accelerating alongside

Can AI Demand Become a Meaningful Growth Engine for Vishay Stock?Photo, wide shot, wide-angle lens,  Computer hardware manufacturer, sunset photo at golden hour, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/8b396c5d-cf01-4937-89c4-91ad2f28f1ee.png
Can AI Demand Become a Meaningful Growth Engine for Vishay Stock?

Artificial intelligence is emerging as one of the most important growth opportunities for Vishay Intertechnology VSH, with management highlighting strong and accelerating demand across multiple

Is NVST Attractive at 15.1x Forward Earnings?
Is NVST Attractive at 15.1x Forward Earnings?

Envista Corporation NVST has started to rebuild investor confidence, but the valuation question is still front and center. The stock trades at 15.1x forward 12-month earnings, a modest premium to

CAVA Group's Tech Stack Could Be the Next Growth Lever
CAVA Group's Tech Stack Could Be the Next Growth Lever

CAVA Group CAVA has been leaning on strong traffic momentum, disciplined pricing and broad consumer appeal across income cohorts. Digital ordering and third-party delivery are supporting guest

HIG to Divest Hartford Funds to Wellington, Unlocking $1.9B ValuePhoto, wide shot, wide-angle lens,  Reinsurance company, Midday, harsh overhead sunlight, directional sunlightt, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/490045fb-8676-41a9-be7a-bcf4281c7d92.png
HIG to Divest Hartford Funds to Wellington, Unlocking $1.9B Value

The Hartford Insurance Group, Inc. HIG has agreed to sell Hartford Funds to its long-time partner, Wellington Management, in a deal with an estimated net present value of $1.9 billion. The deal